Loading clinical trials...
Loading clinical trials...
Imaging Beta-amyloid in Middle Age Alcoholics As a Mechanism That Increases Their Risk for Alzheimer's Disease
Conditions
Interventions
[C-11]
Pittsburgh Compound B
Locations
1
United States
University of Pittsbyurgh PET Facility
Pittsburgh, Pennsylvania, United States
Start Date
December 1, 2018
Primary Completion Date
July 1, 2020
Completion Date
July 1, 2020
Last Updated
December 13, 2024
NCT05855668
NCT07071779
NCT07413458
NCT06793488
NCT06939088
NCT06648642
Lead Sponsor
University of Pittsburgh
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions